Search results for dexamethasone - Clinical Trials Registry - ICH GCP

Example: Heart Attack

Search clinical trials for: dexamethasone

Total 2618 results

NCT05552976

Recruiting

A Study to Evaluate CC-92480 in Combination With Carfilzomib and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

Conditions: Relapsed or Refractory Multiple Myeloma
NCT05519085

Recruiting

A Study to Evaluate CC-92480, Bortezomib and Dexamethasone (480Vd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Conditions: Relapsed or Refractory Multiple Myeloma
NCT03201965

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

Conditions: Amyloidosis
NCT02491632

Active, not recruiting

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

Conditions: Advanced Malignant Neoplasm, Fatigue, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm, Refractory Malignant Neoplasm
NCT02726581

Completed

An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma

Conditions: Multiple Myeloma
NCT03914625

Suspended

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

Conditions: B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome
NCT05623020

Recruiting

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

Conditions: Multiple Myeloma
NCT05572515

Recruiting

A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

Conditions: Relapsed or Refractory Multiple Myeloma
NCT05552222

Recruiting

A Study to Compare Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) in Participants With Newly Diagnosed Multiple Myeloma

Conditions: Multiple Myeloma
NCT05250973

Recruiting

A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis

Conditions: Amyloidosis
NCT05020236

Recruiting

MagnetisMM-5: Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Conditions: Multiple Myeloma
NCT04266977

Recruiting

Restrictive Use of Dexamethasone in Glioblastoma

Conditions: Glioblastoma, Dexamethasone, Steroids
NCT04133636

Recruiting

A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma

Conditions: Multiple Myeloma
NCT05521087

Not yet recruiting

A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias

Conditions: Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Leukemia of Ambiguous Lineage
NCT03582033

Active, not recruiting

A Safety Study of SEA-BCMA in Patients With Multiple Myeloma

Conditions: Multiple Myeloma
NCT04915248

Recruiting

Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.

Conditions: Plasmablastic Lymphoma
NCT04892446

Recruiting

Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma

Conditions: Multiple Myeloma
NCT02332850

Recruiting

Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma

Conditions: Multiple Myeloma
NCT03711474

Active, not recruiting

Dysphagia Following Anterior Cervical Spine Surgery; Single Dose Steroid vs Saline (DysDexVSSal)

Conditions: Dysphagia
NCT05172908

Recruiting

The Effect of Dexamethasone on Rebound Pain in Patients Receiving Ilioinguinal and Iliohypogastric Nerve Block

Conditions: Inguinal Hernia
NCT04200651

Recruiting

Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery

Conditions: Glaucoma, Cataract
NCT04663555

Completed

Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19

Conditions: Covid19, ARDS
NCT05459571

Recruiting

Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma

Conditions: Relapsed or Refractory Large B-cell Lymphoma
NCT05083169

Recruiting

A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma

Conditions: Multiple Myeloma
NCT04643002

Recruiting

Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

Conditions: Plasma Cell Myeloma Refractory